---
title: "Cytokinetics to Announce Second Quarter Results on August 6, 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293662317.md"
description: "In South San Francisco, California on July 23, 2026, Cytokinetics, Incorporated (Nasdaq: CYTK) disclosed its plans to reveal second-quarter figures on August 6, 2026, at 4:00 PM ET. Subsequently, the company's senior leadership will conduct a conference call at 4:30 PM ET to delve into the financial results and give updates on the business."
datetime: "2026-07-23T20:02:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293662317.md)
  - [en](https://longbridge.com/en/news/293662317.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293662317.md)
generator: "portal-rs"
---

# Cytokinetics to Announce Second Quarter Results on August 6, 2026

In South San Francisco, California on July 23, 2026, Cytokinetics, Incorporated (Nasdaq: CYTK) disclosed its plans to reveal second-quarter figures on August 6, 2026, at 4:00 PM ET. Subsequently, the company's senior leadership will conduct a conference call at 4:30 PM ET to delve into the financial results and give updates on the business.

### Related Stocks

- [CYTK.US](https://longbridge.com/en/quote/CYTK.US.md)

## Related News & Research

- [Top Cytokinetics Executive Makes Attention-Grabbing Move With Insider Stock Sale](https://longbridge.com/en/news/296290252.md)
- [Will MYQORZO Traction Amid Weaker Q2 2026 Results Change Cytokinetics' (CYTK) Narrative](https://longbridge.com/en/news/296006872.md)
- [Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares for $265,370](https://longbridge.com/en/news/296267986.md)
- [Cytokinetics grants new-hire equity awards, stock options priced at $74.13 per share](https://longbridge.com/en/news/296264145.md)
- [Equifax declares Q3 2026 distribution of R$ 2.02 per unit, payable Sept. 22](https://longbridge.com/en/news/296941296.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**